Navigation

Newsroom

Category: Allgemein, Knowledge-transfer, Newsroom, Top

In the Erlangen Corona Study, comprising more than 2000 subjects, the risk for developing antibodies against the new coronavirus was tested in patients with arthritis, colitis and psoriasis by the Deutsche Zentrum für Immuntherapie (DZI) and Collaborative Research Center (CRC) 1181. The results of this study were just published in Nature Communications.

Category: Allgemein, Knowledge-transfer, Newsroom

Excessive alcohol consumption has adverse effects on health. However, moderate amounts of alcohol can have positive effects on health under certain circumstances. In a recent paper* published in Nature Communication, a research team from the Friedrich-Alexander University Erlangen-Nürnberg (FAU) shows how alcohol can specifically modulates the immune system protecting from the development of autoimmune diseases.

Category: Allgemein, Newsroom, Top

Millions of people in Europe suffer from chronic inflammatory diseases. There is therefore a strong research interest in deciphering the molecular resolution processes of inflammation with the aim to stop inflammation. For three days, international inflammation researchers will engage in interdis...

Category: Allgemein, Event, Newsroom

Dr. Andreas Ramming, physician at the Department of Internal Medicine 3 - Rheumatology and Immunology (Director: Prof. Dr. med. univ. Georg Schett) and researcher at the Friedrich-Alexander-University Erlangen-Nuremberg (FAU), was successful in the toughest selection procedure for European funding: ...

Category: Allgemein, Knowledge-transfer, Newsroom

The exact causes of chronic inflammatory joint disease such as rheumatoid arthritis are still poorly understood. A team of researchers from the University Hospital Erlangen and the University Erlangen-Nuremberg has now chosen a new approach to better understand the underlying mechanisms. Stephan Cul...

Category: Allgemein, Knowledge-transfer, Newsroom, Top

The German Research Foundation (DFG) is extending the funding of the Collaborative Research Centre 1181 (CRC1181) "Checkpoints for Resolution of Inflammation" managed by Prof. Dr. Georg Schett, spokesperson of the CRC1181 and German Centre for Immunotherapy at the University Hospital Erlangen, for a...